sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
novel
coronaviru
cost
nearli
live
recent
outbreak
diseas
threat
remain
sar
coronaviru
sarscov
like
strain
still
exist
anim
reservoir
therefor
develop
vaccin
sar
grave
need
design
produc
prototyp
sar
vaccin
selfassembl
polypeptid
nanoparticl
repetit
display
sar
bcell
epitop
ctermin
heptad
repeat
viru
spike
protein
biophys
analys
circular
dichroism
transmiss
electron
microscopi
dynam
light
scatter
confirm
comput
design
show
nanoparticl
size
nm
immun
experi
adjuv
perform
balbc
mice
investig
bind
properti
elicit
antibodi
show
highli
conform
specif
coiledcoil
epitop
specif
recogn
nativ
trimer
conform
ctermin
heptad
repeat
region
consequ
antisera
exhibit
neutral
activ
vitro
infect
inhibit
assay
conclud
peptid
nanoparticl
repres
promis
platform
vaccin
design
particular
diseas
character
neutral
epitop
coiledcoil
conform
sarscov
envelop
virus
anim
reservoir
sarscov
like
virus
identifi
bat
reemerg
sar
possibl
sarscov
like
strain
still
exist
anim
reservoir
thu
control
measur
develop
safe
effect
vaccin
need
sever
acut
respiratori
syndromecov
attach
subsequ
entri
target
cell
mediat
spike
glycoprotein
virion
surfac
also
major
induc
neutral
antibodi
spike
protein
compos
two
subunit
figur
receptorbind
domain
rbd
subunit
recogn
hostcel
receptor
human
angiotensinconvert
enzym
subunit
respons
membran
fusion
fusion
peptid
fp
sequenc
follow
two
hydrophob
heptad
repeat
region
coiledcoil
hrn
hrc
separ
larg
interhel
domain
loop
transmembran
tm
domain
cytoplasm
tail
figur
spike
protein
bound
hostcel
receptor
structur
switch
within
heptad
repeat
region
allow
fp
tm
domain
move
near
thu
facilit
fusion
viral
cellular
membran
allow
nucleocapsid
enter
cell
structur
switch
hrn
hrc
refold
trimer
state
form
sixhelix
bundl
three
hrn
helic
arrang
central
parallel
tripl
strand
coiledcoil
pack
exterior
core
outer
layer
three
antiparallel
hrc
strand
protein
coronavirus
import
antigen
determin
induc
neutral
antibodi
sar
vaccin
studi
focus
protein
recent
lokugamag
et
al
report
chimer
coronaviruslik
particl
carri
sarscov
protein
mous
hepat
viru
n
e
protein
protect
mice
challeng
sarscov
also
linig
et
al
show
neutral
antibodi
induc
sarscov
protein
express
recombin
measl
viru
infect
vero
cell
inject
mice
nonetheless
fulllength
protein
use
caution
kam
et
al
report
although
recombin
trimer
sarscov
protein
vaccin
elicit
protect
immun
respons
mice
anti
antibodi
also
mediat
antibodydepend
enhanc
viral
entri
human
b
cell
vitro
anoth
studi
ferret
vaccin
sarscov
fulllength
protein
express
recombin
modifi
vaccinia
ankara
grown
vero
cell
show
enhanc
virul
hepat
induc
sarscov
furthermor
use
sar
protein
vaccin
may
lead
enhanc
diseas
immunopatholog
instead
protect
seen
felin
coronaviru
felin
infecti
periton
viru
given
concern
use
sar
vaccin
strategi
fulllength
protein
use
may
optim
human
henc
best
approach
would
probabl
use
small
protein
epitop
major
neutral
determin
use
receptorbind
domain
sarscov
spike
protein
induc
highli
potent
neutral
antibodi
longterm
protect
immun
furthermor
tripet
et
al
show
antibodi
direct
hrc
domain
sarscov
spike
protein
inhibit
sarscov
replic
vitro
immun
purpos
vital
import
conform
bcell
epitop
vaccin
similar
encount
nativ
protein
sarscov
spike
protein
prefusogen
state
hrc
region
trimer
coiledcoil
therefor
peptid
vaccin
would
display
hrc
trimer
coiledcoil
conform
would
ideal
requir
met
peptid
nanoparticl
develop
laboratori
raman
et
al
describ
design
product
peptid
selfassembl
predict
regular
icosahedr
nanoparticl
nm
diamet
monomer
peptid
build
block
nanoparticl
consist
modifi
pentamer
coiledcoil
cartilag
oligomer
matrix
protein
comp
de
novo
design
trimer
coiledcoil
trimer
coiledcoil
extend
sequenc
describ
tripet
et
al
residu
sar
protein
asvvniqkeidrlnevaknln
nativ
coiledcoil
conform
epitop
maintain
studi
tripet
et
al
epitop
site
shown
effect
inhibitor
viral
infect
compar
anoth
epitop
site
hrc
therefor
design
region
select
coiledcoil
regist
trimer
sequenc
nanoparticl
import
featur
peptid
nanoparticl
repetit
antigen
display
system
form
monom
selfassembl
repetit
display
bcell
epitop
nanoparticl
may
lead
strong
humor
immun
respons
addit
peptid
nanoparticl
raman
et
al
assum
icosahedr
symmetri
mimic
viral
protein
capsid
furthermor
peptid
nanoparticl
would
sole
peptidebas
vaccin
safeti
risk
liveattenu
vaccin
avoid
studi
design
sar
subunit
vaccin
use
modifi
version
peptid
nanoparticl
raman
et
al
modif
includ
replac
cystein
alanin
featur
black
figur
addit
sar
epitop
figur
cterminu
repetit
display
surfac
nanoparticl
expect
antibodi
direct
bcell
epitop
conform
specif
henc
abl
block
fusion
cell
viral
membran
interact
ctermin
heptad
repeat
viral
spike
glycoprotein
thu
prevent
receptorinduc
conform
chang
viru
entri
howev
present
design
particular
thelper
epitop
engin
peptid
sequenc
neither
nanoparticl
core
bcell
epitop
predict
commonli
avail
predict
program
contain
specif
thelper
epitop
haplotyp
balbc
mice
biophys
character
highlight
correct
selfassembl
peptid
nanoparticl
nanomet
size
rang
present
immun
experi
show
protect
antibodi
elicit
without
use
adjuv
conformationspecif
find
suggest
modifi
peptid
nanoparticl
denot
herein
promis
platform
sar
vaccin
design
probabl
also
diseas
character
bcell
epitop
found
coiledcoil
class
fusion
protein
virus
hiv
influenza
paramyxoviru
oligonucleotid
purchas
idtdna
code
sar
bcell
epitop
residu
sar
protein
asvvniqkeidrlnevaknln
anneal
ligat
modifi
ppept
vector
code
peptid
monom
core
particl
result
plasmid
transform
eschericia
coli
strain
plyss
express
cell
novagen
madison
wi
usa
bacteri
growth
done
luria
broth
medium
presenc
ampicillin
chloramphenicol
express
induc
mm
isopropyl
h
express
cell
harvest
centrifug
g
min
frozen
purif
done
denatur
condit
cell
pellet
thaw
ice
resuspend
lysi
buffer
compos
urea
mm
nah
po
mm
tri
mm
ph
lyse
sonic
cell
membran
remov
centrifug
min
g
supernat
incub
nickel
bead
qiagen
valencia
ca
usa
h
protein
contamin
wash
column
use
ph
gradient
first
wash
done
lysi
buffer
second
third
wash
ph
respect
buffer
contain
urea
mm
nah
po
mm
sodium
citrat
mm
imidazol
mm
elut
done
ph
urea
mm
nah
po
mm
sodium
citrat
mm
imidazol
mm
puriti
verifi
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
peptid
ident
confirm
mass
spectrometri
follow
purif
denatur
monomer
peptid
dialyz
refold
buffer
mm
tri
ph
mm
nacl
glycerol
contain
urea
follow
urea
urea
urea
urea
urea
refold
buffer
protein
filter
polyvinyliden
fluorid
membran
filter
dialysi
milipor
slvv
rs
millipor
billerica
usa
circular
dichroism
cd
experi
perform
appli
photophys
pi
star
spectrapolarimet
circular
dichroism
spectra
record
nm
mm
sodium
phosphat
ph
mm
nacl
glycerol
temperatur
denatur
profil
obtain
path
length
cell
mgml
protein
concentr
follow
chang
molar
ellipt
nm
temperatur
increas
rate
hydrodynam
diamet
obtain
malvern
zetas
nano
malvern
worcestershir
uk
equip
laser
measur
done
buffer
contain
mm
tri
ph
mm
nacl
glycerol
sampl
neg
stain
uranyl
acet
spi
peptid
concentr
mgml
electron
micrograph
taken
philip
em
philip
electron
optic
eindhoven
netherland
transmiss
electron
microscop
acceler
voltag
kv
micrograph
scan
dpi
sediment
veloc
analysi
conduct
rpm
g
use
interfer
optic
beckmancoult
xli
analyt
ultracentrifug
beckmancoult
fullerton
ca
usa
doubl
sector
synthet
boundari
cell
equip
sapphir
window
use
match
sampl
refer
menisci
rotor
equilibr
vacuum
period
h
rotor
acceler
rpm
interfer
scan
acquir
interv
h
extinct
coeffici
molecular
mass
partial
specif
volum
solvent
densiti
calcul
use
sednterp
initi
analysi
perform
use
sedfit
obtain
c
distribut
dcdt
obtain
g
distribut
ten
balbc
mice
immun
interperiton
primari
immun
contain
sampl
mm
tri
ph
mm
nacl
glycerol
buffer
mgml
secondari
tertiari
one
booster
immun
day
also
contain
sampl
ph
buffer
mice
kill
bled
day
neg
control
nanoparticl
without
sar
epitop
use
immun
five
mice
immun
procedur
sera
prepar
accord
standard
protocol
ninetysixwel
polystyren
plate
coat
dilut
mgml
sarscov
protein
nativ
hrc
peptid
figur
use
mm
carbon
ph
overnight
ctermin
heptad
repeat
region
construct
nativ
hrc
sequenc
residu
remov
coat
solut
wash
thrice
pb
well
block
bsa
pb
h
sera
dilut
bsa
pb
ad
well
incub
h
sampl
solut
remov
wash
thrice
pb
tween
next
horseradish
peroxidas
conjug
antimous
igg
goat
dilut
ad
well
incub
h
sampl
solut
remov
well
wash
thrice
pb
tween
acid
mm
citrat
ph
h
ad
well
plate
read
nm
neutral
activ
hrc
nanoparticl
antisera
sarscov
infect
vero
cell
assess
neutral
assay
perform
triplic
well
flatbottom
plate
biosafeti
level
laboratori
one
hundr
microlit
sera
contain
antibodi
buffer
alon
mix
sar
viru
contain
plagu
form
unit
dulbecco
modifi
eagl
medium
dmem
gibco
invitrogen
carlsbad
ca
usa
contain
fb
penicillin
streptomycin
fungizon
psf
gibco
invitrogen
deep
dish
plate
viru
incub
sera
h
co
serial
dilut
viru
sera
mixtur
made
dmem
fb
psf
inocul
onto
vero
cell
plate
incub
h
co
inocula
remov
cell
overlaid
ml
seakem
agar
contain
mem
gibco
invitrogen
fb
psf
plate
incub
h
cell
fix
stain
crystal
violet
h
plagu
count
inhibit
viral
infect
antibodi
nanoparticl
alon
nanoparticl
shown
percentag
titer
viru
incub
buffer
alon
protein
shell
virus
built
mani
copi
one
polypeptid
chain
particular
protein
shell
mani
spheric
virus
icosahedr
symmetri
attempt
mimic
natur
design
small
viru
capsid
raman
et
al
design
singl
monomer
peptid
build
block
predict
form
icosahedr
peptid
nanoparticl
idea
behind
design
build
block
symmetri
element
found
icosahedron
fivefold
threefold
twofold
rotat
symmetri
axe
also
found
coiledcoil
use
peptid
coiledcoil
oligomer
domain
respect
symmetri
possibl
design
threedimension
build
block
would
form
peptid
nanoparticl
icosahedr
symmetri
figur
therefor
base
design
raman
et
al
monomer
build
block
peptid
nanoparticl
consist
sequenc
form
trimer
pentamer
coiledcoil
shown
sequenc
figur
monomer
peptid
compos
pentamer
domain
short
linker
trimer
domain
extend
sar
bcell
epitop
sequenc
epitop
shown
elicit
humor
immun
respons
character
neutral
antibodi
moreov
epitop
ideal
suit
extend
de
novo
trimer
coiledcoil
bcell
epitop
trimer
coiledcoil
stepwis
dialysi
monom
selfassembl
peptid
nanoparticl
may
accommod
peptid
chain
case
icosahedron
figur
top
bigger
assembl
icosahedron
peptid
chain
figur
bottom
also
selfassembl
state
intermedi
number
peptid
chain
may
possibl
howev
nanoparticl
regular
icosahedr
symmetri
fact
larger
assembl
probabl
exact
icosahedr
symmetri
would
requir
pentamer
coiledcoil
would
switch
hexam
unlik
comp
oligomer
domain
optim
interhel
contact
pentamer
coiledcoil
trimer
coiledcoil
sequenc
modifi
design
raman
et
al
angl
helic
constrain
disulfid
bridg
figur
experi
howev
show
peptid
nanoparticl
contain
cystein
tend
aggreg
data
shown
therefor
replac
cystein
posit
f
heptad
repeat
coiledcoil
close
glycin
linker
alanin
shown
black
figur
modif
abrog
charact
sequenc
alanin
higher
propens
cystein
evalu
secondari
structur
effect
thermal
denatur
cd
spectroscopi
use
depict
figur
peptid
nanoparticl
show
doubl
minima
nm
characterist
structur
consist
fact
peptid
nanoparticl
compos
coiledcoil
peptid
nanoparticl
seem
thermal
stabl
protein
unfold
figur
comput
model
predict
averag
diamet
nm
peptid
nanoparticl
icosahedr
symmetri
figur
top
similar
size
small
virus
particl
size
immunogen
import
directli
affect
immunogen
studi
use
antigen
coval
coupl
inert
nanobead
differ
size
smaller
particl
nm
shown
elicit
potent
combin
cellular
humor
respons
larger
particl
transmiss
electron
microscopi
tem
reveal
peptid
chain
selfassembl
nanoparticl
spheric
shape
size
rang
nm
figur
compar
valu
predict
comput
model
nonetheless
peptid
nanoparticl
perfectli
spheric
shape
might
complet
regular
presenc
ntermin
amino
acid
peptid
sequenc
form
coiledcoil
six
histidin
use
purif
figur
size
per
volum
analysi
dynam
light
scatter
figur
also
show
nanoparticl
size
compar
tem
result
figur
togeth
data
indic
satisfactori
selfassembl
monomer
peptid
chain
form
singl
nanoparticl
expect
size
rang
investig
size
symmetri
relationship
analyt
ultracentrifug
analys
perform
comput
model
expect
monom
selfassembl
form
icosahedron
molecular
weight
obtain
sediment
veloc
experi
possibl
determin
number
monom
constitut
peptid
nanoparticl
figur
display
plot
normal
sediment
coeffici
distribut
g
distribut
peak
near
use
calcul
friction
ratio
sediment
coeffici
correspond
nanoparticl
molecular
weight
mda
peptid
chain
per
nanoparticl
base
largest
fraction
peptid
nanoparticl
seem
icosahedr
symmetri
model
shown
figur
would
impli
angl
pentam
trimer
averag
slightli
smaller
shown
symmetri
figur
case
smaller
angl
would
allow
monom
coassembl
singl
nanoparticl
howev
clear
g
distribut
tail
distribut
curv
higher
valu
sampl
homogen
rather
contain
mixtur
differ
speci
agre
data
obtain
dl
tem
similarli
padilla
et
al
found
differ
size
speci
design
selfassembl
protein
cage
attribut
certain
degre
flexibl
polymorph
assembl
particl
anoth
use
analysi
character
size
distribut
mixtur
macromolecul
sediment
veloc
run
analyt
ultracentrifug
continu
distribut
molecular
mass
c
c
plot
sampl
highest
concentr
shown
figur
molecular
mass
rang
hundr
thousand
dalton
mda
major
particl
molecular
mass
mda
correspond
averag
peptid
chain
per
particl
evalu
specif
antibodi
elicit
immun
nanoparticl
nanoparticl
qualit
elisa
perform
initi
control
experi
elisa
plate
coat
nanoparticl
without
epitop
see
whether
antibodi
recogn
nanoparticl
core
antisera
bound
strongli
nanoparticl
expect
dilut
rang
figur
logic
sequenc
control
experi
coat
elisa
plate
peptid
nanoparticl
carri
epitop
expect
antibodi
show
strong
recognit
peptid
nanoparticl
epitop
figur
dilut
rang
term
oligomer
state
hrc
peptid
present
monom
trimer
nativ
conform
want
examin
whether
antibodi
obtain
immun
would
bind
form
hrc
specif
either
monomer
trimer
state
therefor
verifi
recognit
nativ
hrc
elisa
plate
coat
sar
protein
hrc
sequenc
form
weakli
stabl
trimer
coil
coil
seen
figur
antisera
dilut
rang
bind
peptid
nativ
form
within
protein
show
strong
immunogen
natur
selfassembl
peptid
nanoparticl
investig
specif
trimer
conform
hrc
construct
forc
hrc
trimer
state
use
coat
elisa
plate
maltosebind
protein
use
express
tag
purif
tag
modifi
sequenc
maintain
construct
trimer
also
stabil
hrc
sequenc
figur
trimer
coiledcoil
dilut
rang
antisera
bound
plate
trimer
construct
figur
hand
plate
coat
synthet
hrc
peptid
figur
form
unfold
monom
bound
elisa
plate
littl
bind
figur
result
trimer
hrc
figur
monomer
hrc
figur
indic
antibodi
produc
conformationspecif
expect
nanoparticl
design
confirm
optim
platform
display
conformationspecif
epitop
particular
coiledcoil
conform
similarli
previou
experi
templatebas
coiledcoil
antigen
sequenc
found
elicit
antibodi
conformationspecif
trimer
prefusogen
state
hrc
abl
bind
postfus
sixhelix
bundl
state
peptid
nanoparticl
design
way
de
novo
trimer
coiledcoil
extend
trimer
coiledcoil
stabil
trimer
coiledcoil
epitop
howev
differ
antibodi
reactiv
like
reflect
fact
consider
fraction
antibodi
direct
core
nanoparticl
also
surfac
access
substanti
degre
anoth
reason
could
trimer
coiledcoil
peptid
nanoparticl
contain
free
ctermin
group
exist
nativ
hrc
peptid
c
amid
previous
shown
ionic
interact
cooh
terminu
protein
import
antigenantibodi
interact
thu
antibodi
made
carboxyl
termini
would
necessarili
recogn
nativ
hrc
peptid
determin
elisa
sera
recogn
prefus
state
sarscov
protein
test
neutral
activ
sarscov
sera
mice
number
immun
sar
nanoparticl
combin
concentr
four
sera
strong
bind
activ
trimer
construct
prefus
state
protein
sera
mice
immun
nanoparticl
alon
similarli
concentr
undilut
concentr
sera
test
abil
neutral
sarscov
viru
infect
result
shown
figur
sera
mice
immun
nanoparticl
show
concentrationdepend
neutral
sarscov
infect
sera
mice
immun
nanoparticl
alon
signific
neutral
activ
conclus
gener
desir
conformationspecif
antibodi
abl
neutral
sarscov
infect
use
nanoparticl
present
system
futur
experi
test
conform
specif
plan
introduc
glycin
prolin
linker
de
novo
trimer
coiledcoil
epitop
disrupt
coiledcoil
heptad
repeat
two
sequenc
design
would
expect
observ
loss
conform
specif
immun
respons
weaker
trimer
coiledcoil
hrc
epitop
also
engin
pandr
tcell
epitop
padr
peptid
sequenc
test
influenc
known
thelper
epitop
immunogen
nanoparticl
construct
promis
result
obtain
next
step
includ
challeng
mice
viru
test
whether
anim
recov
infect
present
platform
novel
sar
subunit
vaccin
advantag
peptidebas
vaccin
lack
infect
eas
protein
express
purif
high
puriti
stabil
furthermor
antibodi
sar
spike
protein
conformationspecif
recogn
prefus
trimer
conform
hrc
neutral
activ
sarscov
antisar
antibodi
obtain
without
adjuv
immunogen
effect
system
nanomet
size
particl
repetit
display
epitop
good
mimicri
epitop
nativ
conform
thu
selfassembl
polypeptid
nanoparticl
great
potenti
employ
vaccin
versatil
antigenpres
system
good
humor
immun
respons
obtain
nativ
hrc
sequenc
schemat
maltosebind
protein
mbp
fusion
construct
mbp
use
express
tag
purif
tag
modifi
sequenc
stabil
hrc
sequenc
trimer
coiledcoil
maintain
construct
trimer
sequenc
shown
purpl
transmiss
electron
microscopi
imag
nanoparticl
sampl
neg
stain
uranyl
acet
sampl
concentr
mg
ml
buffer
mm
tri
ph
mm
nacl
glycerol
nanoparticl
size
rang
nm
b
dynam
light
scatter
data
size
distribut
volum
show
peak
correspond
size
nm
sampl
concentr
mgml
buffer
mm
tri
ph
mm
nacl
glycerol
vitro
sarscov
neutral
activ
antibodi
nanoparticl
neutral
shown
percentag
viru
plu
buffer
alon
nanoparticl
sera
significantli
inhibit
sarscov
infect
vero
cell
wherea
antisera
nanoparticl
alon
neutral
viru
infect
